FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256427470> ?p ?o ?g. }

• W4256427470 abstract "Background Interval debulking surgery (IDS), following induction or neoadjuvant chemotherapy, may have a possible role in treating advanced epithelial ovarian cancer (stage III to IV) where primary debulking surgery is not an option. Objectives To assess the effectiveness and complications of IDS for patients with advanced stage epithelial ovarian cancer. Search methods We searched the Cochrane Gynaecological Cancer Group's Specialised Register to July 2009, the Cochrane Central Register of Controlled Trials (CENTRAL) Issue 2, 2009, MEDLINE from January 1966 to June week 4 2009, and EMBASE from January 1966 to week 27 2009. Selection criteria Randomised controlled trials (RCTs) comparing survival of women with advanced epithelial ovarian cancer, who had IDS performed between cycles of chemotherapy after primary surgery with survival of women who had conventional treatment (primary debulking surgery and adjuvant chemotherapy). Data collection and analysis Two review authors independently assessed trial quality and extracted data. Searches for additional information from study authors were attempted. Meta‐analysis of overall and progression‐free survival (PFS) were performed using random‐effects models. Main results Three RCTs randomising 853 women, of whom 781 were evaluated, met the inclusion criteria. Meta‐analysis of three trials for overall survival (OS) found no statistically significant difference between IDS and chemotherapy alone (hazard ratio (HR) = 0.80, 95% confidence interval (CI) 0.61 to 1.06, I2 = 58%). Subgroup analysis for OS in two trials, where the primary surgery was not performed by gynaecologic oncologists or was less extensive, showed a benefit of IDS: HR = 0.68, 95% CI 0.53 to 0.87, I2 = 0%). Meta‐analysis of two trials for progression‐free survival (PFS) found no statistically significant difference between IDS and chemotherapy alone (HR = 0.88, 95% CI 0.57 to 1.33, I2 = 83%). Rates of toxic reactions to chemotherapy were similar in both arms (risk ratio = 1.19, 95% CI 0.53 to 2.66, I2 = 0%), but little information was available for other adverse events or quality or life. Authors' conclusions No conclusive evidence was found to determine whether IDS between cycles of chemotherapy would improve or decrease the survival rates of women with advanced ovarian cancer, compared with conventional treatment of primary surgery followed by adjuvant chemotherapy. IDS appeared to yield benefit only in patients whose primary surgery was not performed by gynaecologic oncologists or was less extensive. Data on QoL and adverse events were inconclusive." @default.
• W4256427470 created "2022-05-12" @default.
• W4256427470 creator A5034751333 @default.
• W4256427470 creator A5038971195 @default.
• W4256427470 creator A5042093250 @default.
• W4256427470 creator A5050207691 @default.
• W4256427470 creator A5089881146 @default.
• W4256427470 date "2010-10-06" @default.
• W4256427470 modified "2023-10-05" @default.
• W4256427470 title "Interval debulking surgery for advanced epithelial ovarian cancer" @default.
• W4256427470 cites W1598602811 @default.
• W4256427470 cites W1973312028 @default.
• W4256427470 cites W1977958507 @default.
• W4256427470 cites W1982421876 @default.
• W4256427470 cites W1989331806 @default.
• W4256427470 cites W1990872296 @default.
• W4256427470 cites W2003034240 @default.
• W4256427470 cites W2005947177 @default.
• W4256427470 cites W2010005160 @default.
• W4256427470 cites W2010295336 @default.
• W4256427470 cites W2010626202 @default.
• W4256427470 cites W2013298015 @default.
• W4256427470 cites W2034373652 @default.
• W4256427470 cites W2043456408 @default.
• W4256427470 cites W2056111107 @default.
• W4256427470 cites W2060922610 @default.
• W4256427470 cites W2066487772 @default.
• W4256427470 cites W2073547162 @default.
• W4256427470 cites W2075642745 @default.
• W4256427470 cites W2081771308 @default.
• W4256427470 cites W2096696139 @default.
• W4256427470 cites W2102727282 @default.
• W4256427470 cites W2103152246 @default.
• W4256427470 cites W2107328434 @default.
• W4256427470 cites W2115247765 @default.
• W4256427470 cites W2125435699 @default.
• W4256427470 cites W2151465507 @default.
• W4256427470 cites W2151879224 @default.
• W4256427470 cites W2403755229 @default.
• W4256427470 cites W2434408481 @default.
• W4256427470 cites W2597648837 @default.
• W4256427470 cites W4232721722 @default.
• W4256427470 cites W4233920089 @default.
• W4256427470 cites W4234756044 @default.
• W4256427470 cites W4239451229 @default.
• W4256427470 cites W4250894715 @default.
• W4256427470 cites W4368092894 @default.
• W4256427470 doi "https://doi.org/10.1002/14651858.cd006014.pub5" @default.
• W4256427470 hasPublicationYear "2010" @default.
• W4256427470 type Work @default.
• W4256427470 citedByCount "11" @default.
• W4256427470 countsByYear W42564274702012 @default.
• W4256427470 countsByYear W42564274702013 @default.
• W4256427470 countsByYear W42564274702015 @default.
• W4256427470 countsByYear W42564274702017 @default.
• W4256427470 countsByYear W42564274702020 @default.
• W4256427470 countsByYear W42564274702022 @default.
• W4256427470 crossrefType "reference-entry" @default.
• W4256427470 hasAuthorship W4256427470A5034751333 @default.
• W4256427470 hasAuthorship W4256427470A5038971195 @default.
• W4256427470 hasAuthorship W4256427470A5042093250 @default.
• W4256427470 hasAuthorship W4256427470A5050207691 @default.
• W4256427470 hasAuthorship W4256427470A5089881146 @default.
• W4256427470 hasConcept C121608353 @default.
• W4256427470 hasConcept C126322002 @default.
• W4256427470 hasConcept C141071460 @default.
• W4256427470 hasConcept C143998085 @default.
• W4256427470 hasConcept C146357865 @default.
• W4256427470 hasConcept C151730666 @default.
• W4256427470 hasConcept C168563851 @default.
• W4256427470 hasConcept C207103383 @default.
• W4256427470 hasConcept C2776694085 @default.
• W4256427470 hasConcept C2780427987 @default.
• W4256427470 hasConcept C2781100745 @default.
• W4256427470 hasConcept C2992773878 @default.
• W4256427470 hasConcept C44249647 @default.
• W4256427470 hasConcept C71924100 @default.
• W4256427470 hasConcept C86803240 @default.
• W4256427470 hasConcept C95190672 @default.
• W4256427470 hasConceptScore W4256427470C121608353 @default.
• W4256427470 hasConceptScore W4256427470C126322002 @default.
• W4256427470 hasConceptScore W4256427470C141071460 @default.
• W4256427470 hasConceptScore W4256427470C143998085 @default.
• W4256427470 hasConceptScore W4256427470C146357865 @default.
• W4256427470 hasConceptScore W4256427470C151730666 @default.
• W4256427470 hasConceptScore W4256427470C168563851 @default.
• W4256427470 hasConceptScore W4256427470C207103383 @default.
• W4256427470 hasConceptScore W4256427470C2776694085 @default.
• W4256427470 hasConceptScore W4256427470C2780427987 @default.
• W4256427470 hasConceptScore W4256427470C2781100745 @default.
• W4256427470 hasConceptScore W4256427470C2992773878 @default.
• W4256427470 hasConceptScore W4256427470C44249647 @default.
• W4256427470 hasConceptScore W4256427470C71924100 @default.
• W4256427470 hasConceptScore W4256427470C86803240 @default.
• W4256427470 hasConceptScore W4256427470C95190672 @default.
• W4256427470 hasLocation W42564274701 @default.
• W4256427470 hasOpenAccess W4256427470 @default.
• W4256427470 hasPrimaryLocation W42564274701 @default.
• W4256427470 hasRelatedWork W1900595920 @default.
• W4256427470 hasRelatedWork W2133480631 @default.

• next